Exosomes and their Application in Biomedical Field: Difficulties and Advantages

Molecular Neurobiology

Volumn 55, Issue 4, 2018, Pages 3372-3393

  Rezaie, Jafar ^a,b   Ajezi, Saeed ^a,c   Avci, r Biray ^d   Karimipour, Mohammad ^c   Geranmayeh, Mohammad Hossein ^a,e   Nourazarian, Alireza ^a,c   Sokullu, Emel ^f   Rezabakhsh, Aysa ^a,g   Rahbarghazi, Reza ^a,g  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b URMIA UNIVERSITY   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d EGE UNIVERSITY   (Turkey)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f IZMIR KATIP CELEBI UNIVERSITY   (Turkey)

^g TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Biological carrier; Exosome; Gene delivery; Genetic engineering; Therapeutic nanoparticles

Indexed keywords

BIOLOGICAL MARKER; NANOMATERIAL; VIRUS VECTOR; MICRORNA;

BIOMEDICINE; CARDIOVASCULAR DISEASE; CELL FUSION; CELL INTERACTION; CELL KINETICS; CELL MEMBRANE; CELL TRANSPORT; DEGENERATIVE DISEASE; DNA SEQUENCE; DRUG DELIVERY SYSTEM; ENDOSOMAL SORTING COMPLEX FOR TRANSPORT; EXOSOME; GENE TARGETING; GENE THERAPY; GENETIC ENGINEERING; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; INFLAMMATION; LIPID COMPOSITION; MULTIVESICULAR BODY; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PATIENT SAFETY; PROCESS DEVELOPMENT; PROTEIN ANALYSIS; REVIEW; RISK BENEFIT ANALYSIS; ANIMAL; GENETICS; MEDICAL RESEARCH; METABOLISM; PATHOLOGY;

ANIMALS; BIOMEDICAL RESEARCH; DRUG DELIVERY SYSTEMS; EXOSOMES; GENETIC THERAPY; HUMANS; MICRORNAS; NEURODEGENERATIVE DISEASES;

EID: 85019095847     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-017-0582-7     Document Type: Review

References (219)

1. Tan A, Rajadas J, Seifalian AM (2012) Exosomes as nano-theranostic delivery platforms for gene therapy. Adv Drug Deliv Rev 65(3):357–367. doi:10.1016/j.addr.2012.06.014
2. Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L, Scaramuzza S, Andolfi G et al (2009) Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 360(5):447–458. doi:10.1056/NEJMoa0805817
3. Verma IM, Somia N (1997) Gene therapy—promises, problems and prospects. Nature 389(6648):239–242. doi:10.1038/38410
4. Tani J, Faustine SJT (2011) Updates on current advances in gene therapy. West Indian Med J 60(2):188–194
5. Li S, Huang L (2000) Nonviral gene therapy: promises and challenges. Gene Ther 7(1):31–34. doi:10.1038/sj.gt.3301110
6. van den Boorn JG, Dassler J, Coch C, Schlee M, Hartmann G (2013) Exosomes as nucleic acid nanocarriers. Adv Drug Deliv Rev 65(3):331–335. doi:10.1016/j.addr.2012.06.011
7. Lässer C (2012) Exosomal RNA as biomarkers and the therapeutic potential of exosome vectors. Expert Opin Biol Ther 12(sup1):S189–S197
8. Lässer C, Théry C, Buzás EI, Mathivanan S, Zhao W, Gho YS, Lötvall J (2016) The International Society for Extracellular Vesicles launches the first massive open online course on extracellular vesicles. J Extracell Vesicles 5(1):34299. doi:10.3402/jev.v5.34299
9. Mountain A (2000) Gene therapy: the first decade. Trends Biotechnol 18(3):119–128
10. Mulligan RC (1993) The basic science of gene therapy. Science 260(5110):926–932. doi:10.1126/science.8493530
11. Gorecki DC (2001) Prospects and problems of gene therapy: an update. Expert Opin Emerg Drugs 6(2):187–198. doi:10.1517/14728214.6.2.187
12. Mintzer MA, Simanek EE (2009) Nonviral vectors for gene delivery. Chem Rev 109(2):259–302. doi:10.1021/cr800409e
13. Thomas CE, Ehrhardt A, Kay MA (2003) Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4(5):346–358. doi:10.1038/nrg1066
14. Pfeifer A, Verma IM (2001) Gene therapy: promises and problems. Annu Rev Genomics Hum Genet 2:177–211. doi:10.1146/annurev.genom.2.1.177
15. Roth JA, Cristiano RJ (1997) Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst 89(1):21–39
16. Pouton CW, Seymour LW (2001) Key issues in non-viral gene delivery. Adv Drug Deliv Rev 46(1–3):187–203 doi: S0169-409X(98)00048-9
17. Schmidt-Wolf GD, Schmidt-Wolf IG (2003) Non-viral and hybrid vectors in human gene therapy: an update. Trends Mol Med 9(2):67–72. doi:10.1016/S1471-4914(03)00005-4
18. Horn NA, Meek JA, Budahazi G, Marquet M (1995) Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials. Hum Gene Ther 6(5):565–573. doi:10.1089/hum.1995.6.5-565
19. Lui VW, Falo LD Jr, Huang L (2001) Systemic production of IL-12 by naked DNA mediated gene transfer: toxicity and attenuation of transgene expression in vivo. J Gene Med 3(4):384–393. doi:10.1002/jgm.201
20. Canatella PJ, Prausnitz MR (2001) Prediction and optimization of gene transfection and drug delivery by electroporation. Gene Ther 8(19):1464–1469. doi:10.1038/sj.gt.3301547
21. Buttgereit P, Schmidt-Wolf IG (2002) Gene therapy of lymphoma. J Hematother Stem Cell Res 11(3):457–467. doi:10.1089/15258160260090924
22. Yang NS, Burkholder J, Roberts B, Martinell B, McCabe D (1990) In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci U S A 87(24):9568–9572
23. Wittig B, Marten A, Dorbic T, Weineck S, Min H, Niemitz S, Trojaneck B, Flieger D et al (2001) Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial. Hum Gene Ther 12(3):267–278. doi:10.1089/10430340150218404
24. Fenske DB, MacLachlan I, Cullis PR (2002) Stabilized plasmid-lipid particles: a systemic gene therapy vector. Methods Enzymol 346:36–71
25. Schaffert D, Wagner E (2008) Gene therapy progress and prospects: synthetic polymer-based systems. Gene Ther 15(16):1131–1138. doi:10.1038/gt.2008.105
26. Dobson J (2006) Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther 13(4):283–287. doi:10.1038/sj.gt.3302720
27. Herzog RW, Cao O, Srivastava A (2010) Two decades of clinical gene therapy—success is finally mounting. Discov Med 9(45):105–111
28. Alexander BL, Ali RR, Alton EW, Bainbridge JW, Braun S, Cheng SH, Flotte TR, Gaspar HB et al (2007) Progress and prospects: gene therapy clinical trials (part 1). Gene Ther 14(20):1439–1447. doi:10.1038/sj.gt.3303001
29. Aiuti A, Bachoud-Levi AC, Blesch A, Brenner MK, Cattaneo F, Chiocca EA, Gao G, High KA et al (2007) Progress and prospects: gene therapy clinical trials (part 2). Gene Ther 14(22):1555–1563. doi:10.1038/sj.gt.3303033
30. Pan B-T, Teng K, Wu C, Adam M, Johnstone RM (1985) Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol 101(3):942–948
31. Harding C, Heuser J, Stahl P (1983) Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol 97(2):329–339
32. Johnstone RM, Adam M, Hammond J, Orr L, Turbide C (1987) Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 262(19):9412–9420
33. Mathivanan S, Simpson RJ (2009) ExoCarta: a compendium of exosomal proteins and RNA. Proteomics 9(21):4997–5000. doi:10.1002/pmic.200900351
34. Caby M-P, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C (2005) Exosomal-like vesicles are present in human blood plasma. Int Immunol 17(7):879–887. doi:10.1093/intimm/dxh267
35. Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C et al (2002) Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360(9329):295–305. doi:10.1016/S0140-6736(02)09552-1
36. Asea A, Jean-Pierre C, Kaur P, Rao P, Linhares IM, Skupski D, Witkin SS (2008) Heat shock protein-containing exosomes in mid-trimester amniotic fluids. J Reprod Immunol 79(1):12–17. doi:10.1016/j.jri.2008.06.001
37. Vella L, Sharples R, Lawson V, Masters C, Cappai R, Hill A (2007) Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol 211(5):582–590. doi:10.1002/path.2145
38. Pisitkun T, Shen R-F, Knepper MA (2004) Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 101(36):13368–13373. doi:10.1073/pnas.0403453101
39. Lässer C, Alikhani VS, Ekström K, Eldh M, Paredes PT, Bossios A, Sjöstrand M, Gabrielsson S et al (2011) Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med 9(1):1. doi:10.1186/1479-5876-9-9
40. Admyre C, Grunewald J, Thyberg J, Gripenbäck S, Tornling G, Eklund A, Scheynius A, Gabrielsson S (2003) Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur Respir J 22(4):578–583. doi:10.1183/09031936.03.00041703
41. Masyuk AI, Huang BQ, Ward CJ, Gradilone SA, Banales JM, Masyuk TV, Radtke B, Splinter PL et al (2010) Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia. Am J Physiol Gastrointest Liver Physiol 299(4):G990–G999. doi:10.1152/ajpgi.00093.2010
42. De Toro J, Herschlik L, Waldner C, Mongini C (2015) Emerging roles of Exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front Immunol 6:203. doi:10.3389/fimmu.2015.00203
43. Buschow SI, Van Niel G, Pols MS, Ten Broeke T, Lauwen M, Ossendorp F, Melief CJ, Raposo G et al (2009) MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic 10(10):1528–1542. doi:10.1111/j.1600-0854.2009.00963.x
44. Théry C, Ostrowski M, Segura E (2009) Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9(8):581–593. doi:10.1038/nri2567
45. Moon TC, Befus AD, Kulka M (2014) Mast cell mediators: their differential release and the secretory pathways involved. Front Immunol 5:569. doi:10.3389/fimmu.2014.00569
46. Qu Y, Dubyak GR (2009) P2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathways. Purinergic Signal 5(2):163–173. doi:10.1007/s11302-009-9132-8
47. Zhang X, Yuan X, Shi H, Wu L, Qian H, Xu W (2015) Exosomes in cancer: small particle, big player. J Hematol Oncol 8:83. doi:10.1186/s13045-015-0181-x
48. Gould SJ, Raposo G (2013) As we wait: coping with an imperfect nomenclature for extracellular vesicles. J Extracell Vesicles 2:20389. doi:10.3402/jev.v2i0.20389
49. Conde-Vancells J, Rodriguez-Suarez E, Embade N, Gil D, Matthiesen R, Valle M, Elortza F, Lu SC et al (2008) Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J Proteome Res 7(12):5157–5166
50. Willms E, Johansson HJ, Mäger I, Lee Y, Blomberg KEM, Sadik M, Alaarg A, Smith CE et al (2016) Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci Rep 6:22519. doi:10.1038/srep22519
51. Chaput N, Théry C (2011) Exosomes: immune properties and potential clinical implementations. Semin Immunopathol 33(5):419–440. doi:10.1007/s00281-010-0233-9
52. Keller S, Sanderson MP, Stoeck A, Altevogt P (2006) Exosomes: from biogenesis and secretion to biological function. Immunol Lett 107(2):102–108. doi:10.1016/j.imlet.2006.09.005
53. Ludwig AK, Giebel B (92012) Exosomes: small vesicles participating in intercellular communication. Int J Biochem Cell Biol 44(1):11–15. doi:10.1016/j.biocel.2011.10.005
54. Kleijmeer M, Ramm G, Schuurhuis D, Griffith J, Rescigno M, Ricciardi-Castagnoli P, Rudensky AY, Ossendorp F et al (2001) Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells. J Cell Biol 155(1):53–64. doi:10.1083/jcb.200103071
55. Murk J, Posthuma G, Koster A, Geuze H, Verkleij A, Kleijmeer M, Humbel B (2003) Influence of aldehyde fixation on the morphology of endosomes and lysosomes: quantitative analysis and electron tomography. J Microsc 212(1):81–90
56. Johnstone RM (2006) Exosomes biological significance: a concise review. Blood Cells Mol Dis 36(2):315–321. doi:10.1016/j.bcmd.2005.12.001
57. Möbius W, Ohno-Iwashita Y, van Donselaar EG, Oorschot VM, Shimada Y, Fujimoto T, Heijnen HF, Geuze HJ et al (2002) Immunoelectron microscopic localization of cholesterol using biotinylated and non-cytolytic perfringolysin O. J Histochem Cytochem 50(1):43–55. doi:10.1177/002215540205000105
58. White IJ, Bailey LM, Aghakhani MR, Moss SE, Futter CE (2006) EGF stimulates annexin 1-dependent inward vesiculation in a multivesicular endosome subpopulation. EMBO J 25(1):1–12. doi:10.1038/sj.emboj.7600759
59. Hurley JH, Hanson PI (2010) Membrane budding and scission by the ESCRT machinery: it’s all in the neck. Nat Rev Mol Cell Biol 11(8):556–566
60. Raiborg C, Stenmark H (2009) The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 458(7237):445–452. doi:10.1038/nature07961
61. Stuffers S, Sem Wegner C, Stenmark H, Brech A (2009) Multivesicular endosome biogenesis in the absence of ESCRTs. Traffic 10(7):925–937. doi:10.1111/j.1600-0854.2009.00920.x
62. Vlassov AV, Magdaleno S, Setterquist R, Conrad R (2012) Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 7:940–948. doi:10.1016/j.bbagen.2012.03.017
63. Hanson PI, Cashikar A (2012) Multivesicular body morphogenesis. Annu Rev Cell Dev Biol 28:337–362. doi:10.1146/annurev-cellbio-092910-154152
64. Henne WM, Stenmark H, Emr SD (2013) Molecular mechanisms of the membrane sculpting ESCRT pathway. Cold Spring Harb Perspect Biol. 5(9). doi:10.1101/cshperspect.a016766
65. Abrami L, Brandi L, Moayeri M, Brown MJ, Krantz BA, Leppla SH, van der Goot FG (2013) Hijacking multivesicular bodies enables long-term and exosome-mediated long-distance action of anthrax toxin. Cell Rep 5(4):986–996. doi:10.1016/j.celrep.2013.10.019
66. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, Ivarsson Y, Depoortere F et al (2012) Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 14(7):677–685. doi:10.1038/ncb2502
67. Hoshino D, Kirkbride KC, Costello K, Clark ES, Sinha S, Grega-Larson N, Tyska MJ, Weaver AM (2013) Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Rep 5(5):1159–1168. doi:10.1016/j.celrep.2013.10.050
68. Gruenberg J, Stenmark H (2004) The biogenesis of multivesicular endosomes. Nat Rev Mol Cell Biol 5(4):317–323. doi:10.1038/nrm1360
69. Sahu R, Kaushik S, Clement CC, Cannizzo ES, Scharf B, Follenzi A, Potolicchio I, Nieves E et al (2011) Microautophagy of cytosolic proteins by late endosomes. Dev Cell 20(1):131–139. doi:10.1016/j.devcel.2010.12.003
70. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brügger B et al (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319(5867):1244–1247. doi:10.1126/science
71. van Niel G, Charrin S, Simoes S, Romao M, Rochin L, Saftig P, Marks MS, Rubinstein E et al (2011) The tetraspanin CD63 regulates ESCRT-independent and-dependent endosomal sorting during melanogenesis. Dev Cell 21(4):708–721. doi:10.1016/j.devcel.2011.08.019
72. Butler JS (2002) The yin and yang of the exosome. Trends Cell Biol 12(2):90–96
73. Edgar JR, Eden ER, Futter CE (2014) Hrs-and CD63-dependent competing mechanisms make different sized endosomal intraluminal vesicles. Traffic 15(2):197–211. doi:10.1111/tra.12139
74. Theos AC, Truschel ST, Tenza D, Hurbain I, Harper DC, Berson JF, Thomas PC, Raposo G et al (2006) A lumenal domain-dependent pathway for sorting to intralumenal vesicles of multivesicular endosomes involved in organelle morphogenesis. Dev Cell 10(3):343–354. doi:10.1016/j.devcel.2006.01.012
75. Nazarenko I, Rana S, Baumann A, McAlear J, Hellwig A, Trendelenburg M, Lochnit G, Preissner KT et al (2010) Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res 70(4):1668–1678. doi:10.1158/0008-5472.CAN-09-2470
76. Lorentzen E, Conti E (2006) The exosome and the proteasome: nano-compartments for degradation. Cell 125(4):651–654 doi:S0092-8674(06)00567-8
77. Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ (2010) Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol 190(6):1079–1091. doi:10.1083/jcb.201002049
78. Dreux M, Garaigorta U, Boyd B, Décembre E, Chung J, Whitten-Bauer C, Wieland S, Chisari FV (2012) Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 12(4):558–570. doi:10.1016/j.chom.2012.08.010
79. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285(23):17442–17452. doi:10.1074/jbc.M110.107821
80. Tanaka N, Kyuuma M, Sugamura K (2008) Endosomal sorting complex required for transport proteins in cancer pathogenesis, vesicular transport, and non-endosomal functions. Cancer Sci 99(7):1293–1303. doi:10.1111/j.1349-7006.2008.00825
81. Stoorvogel W (2015) Resolving sorting mechanisms into exosomes. Cell Res 25(5):531–532. doi:10.1038/cr.2015.39
82. Strauss K, Goebel C, Runz H, Möbius W, Weiss S, Feussner I, Simons M, Schneider A (2010) Exosome secretion ameliorates lysosomal storage of cholesterol in Niemann-Pick type C disease. J Biol Chem 285(34):26279–26288. doi:10.1074/jbc.M110.134775
83. Ghossoub R, Lembo F, Rubio A, Gaillard CB, Bouchet J, Vitale N, Slavík J, Machala M et al (2014) Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2. Nat Commun 5:3477. doi:10.1038/ncomms4477
84. Laulagnier K, Grand D, Dujardin A, Hamdi S, Vincent-Schneider H, Lankar D, Salles J-P, Bonnerot C et al (2004) PLD2 is enriched on exosomes and its activity is correlated to the release of exosomes. FEBS Lett 572(1–3):11–14. doi:10.1016/j.febslet.2004.06.082
85. Hutagalung AH, Novick PJ (2011) Role of Rab GTPases in membrane traffic and cell physiology. Physiol Rev 91(1):119–149. doi:10.1152/physrev.00059.2009
86. Fader CM, Sánchez DG, Mestre MB, Colombo MI (2009) TI-VAMP/VAMP7 and VAMP3/cellubrevin: two v-SNARE proteins involved in specific steps of the autophagy/multivesicular body pathways. Biochim Biophys Acta 1793(12):1901–1916. doi:10.1016/j.bbamcr.2009.09.011
87. Chaineau M, Danglot L, Galli T (2009) Multiple roles of the vesicular-SNARE TI-VAMP in post-Golgi and endosomal trafficking. FEBS Lett 583(23):3817–3826. doi:10.1016/j.febslet.2009.10.026
88. Puri N, Roche PA (2008) Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms. Proc Natl Acad Sci U S A 105(7):2580–2585. doi:10.1073/pnas.0707854105
89. Rao SK, Huynh C, Proux-Gillardeaux V, Galli T, Andrews NW (2004) Identification of SNAREs involved in synaptotagmin VII-regulated lysosomal exocytosis. J Biol Chem 279(19):20471–20479. doi:10.1074/jbc.M400798200
90. Tiwari N, Wang C-C, Brochetta C, Ke G, Vita F, Qi Z, Rivera J, Soranzo MR et al (2008) VAMP-8 segregates mast cell-preformed mediator exocytosis from cytokine trafficking pathways. Blood 111(7):3665–3674. doi:10.1182/blood-2007-07-103309
91. Proux-Gillardeaux V, Raposo G, Irinopoulou T, Galli T (2007) Expression of the Longin domain of TI-VAMP impairs lysosomal secretion and epithelial cell migration. Biol Cell 99(5):261–271. doi:10.1042/BC20060097
92. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, Geuze HJ (1996) B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183(3):1161–1172
93. Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J, Ratajczak MZ (2005) Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 113(5):752–760. doi:10.1002/ijc.20657
94. Lakkaraju A, Rodriguez-Boulan E (2008) Itinerant exosomes: emerging roles in cell and tissue polarity. Trends Cell Biol 18(5):199–209. doi:10.1016/j.tcb.2008.03.002
95. Yeo RW, Lai RC, Zhang B, Tan SS, Yin Y, Teh BJ, Lim SK (2013) Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. Adv Drug Deliv Rev 65(3):336–341. doi:10.1016/j.addr.2012.07.001
96. Eldh M, Ekstrom K, Valadi H, Sjostrand M, Olsson B, Jernas M, Lotvall J (2010) Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA. PLoS One 5(12):e15353. doi:10.1371/journal.pone.0015353
97. Meckes DG, Jr., Shair KH, Marquitz AR, Kung CP, Edwards RH, Raab-Traub N (2010) Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci U S A 107(47):20370–20375. doi:10.1073/pnas.1014194107
98. El Andaloussi S, Lakhal S, Mager I, Wood MJ (2013) Exosomes for targeted siRNA delivery across biological barriers. Adv Drug Deliv Rev 65(3):391–397. doi:10.1016/j.addr.2012.08.008
99. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJA (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29(4):341–345. doi:10.1038/nbt.1807
100. Taylor DD, Gercel-Taylor C (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110(1):13–21. doi:10.1016/j.ygyno.2008.04.033
101. Marcus ME, Leonard JN (2013) FedExosomes: engineering therapeutic biological nanoparticles that truly deliver. Pharmaceuticals (Basel) 6(5):659–680. doi:10.3390/ph6050659
102. Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, Sun F, Lu J et al (2010) Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 39(1):133–144. doi:10.1016/j.molcel.2010.06.010
103. Bryniarski K, Ptak W, Jayakumar A, Püllmann K, Caplan MJ, Chairoungdua A, Lu J, Adams BD, Sikora E, Nazimek K (2013) Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. J Allergy Clin Immunol 132(1):170–181. doi: 10.1016/j.jaci.2013.04.048
104. Xin H, Li Y, Buller B, Katakowski M, Zhang Y, Wang X, Shang X, Zhang ZG et al (2012) Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 30(7):1556–1564. doi:10.1002/stem.1129
105. Chen L, Charrier A, Zhou Y, Chen R, Yu B, Agarwal K, Tsukamoto H, Lee LJ et al (2014) Epigenetic regulation of connective tissue growth factor by microRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology 59(3):1118–1129. doi:10.1002/hep.26768
106. Cooper JM, Wiklander P, Nordin JZ, Al-Shawi R, Wood MJ, Vithlani M, Schapira AH, Simons JP et al (2014) Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov Disord 29(12):1476–1485. doi:10.1002/mds.25978
107. Katakowski M, Zheng X, Jiang F, Rogers T, Szalad A, Chopp M (2010) MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma. Cancer Investig 28(10):1024–1030. doi:10.3109/07357907.2010.512596
108. Ohno S, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N, Fujita K, Mizutani T et al (2013) Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther 21(1):185–191. doi:10.1038/mt.2012.180
109. Kosaka N, Iguchi H, Yoshioka Y, Hagiwara K, Takeshita F, Ochiya T (2012) Competitive interactions of cancer cells and normal cells via secretory microRNAs. J Biol Chem 287(2):1397–1405
110. Mizrak A, Bolukbasi MF, Ozdener GB, Brenner GJ, Madlener S, Erkan EP, Ströbel T, Breakefield XO et al (2013) Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth. Mol Ther 21(1):101–108. doi:10.1038/mt.2012.161
111. Shtam TA, Kovalev RA, Varfolomeeva EY, Makarov EM, Kil YV, Filatov MV (2013) Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Commun Signal 11:88. doi:10.1186/1478-811X-11-88
112. Momen-Heravi F, Bala S, Bukong T, Szabo G (2014) Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages. Nanomedicine 10(7):1517–1527. doi:10.1016/j.nano.2014.03.014
113. Wahlgren J, De LKT, Brisslert M, Vaziri Sani F, Telemo E, Sunnerhagen P, Valadi H (2012) Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res 40(17):e130. doi:10.1093/nar/gks463
114. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nature biotechnol 29(4):341–345
115. Liu Y, Li D, Liu Z, Zhou Y, Chu D, Li X, Jiang X, Hou D et al (2015) Targeted exosome-mediated delivery of opioid receptor mu siRNA for the treatment of morphine relapse. Sci Rep 5:17543. doi:10.1038/srep17543
116. Pan Q, Ramakrishnaiah V, Henry S, Fouraschen S, de Ruiter PE, Kwekkeboom J, Tilanus HW, Janssen HL et al (2011) Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi). Gut 61(9):1330–1339. doi:10.1136/gutjnl-2011-300449
117. Xin H, Li Y, Liu Z, Wang X, Shang X, Cui Y, Zhang ZG, Chopp M (2013) MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells 31(12):2737–2746. doi:10.1002/stem.1409
118. Bryniarski K, Ptak W, Jayakumar A, Pullmann K, Caplan MJ, Chairoungdua A, Lu J, Adams BD et al (2013) Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. J Allergy Clin Immunol 132(1):170–181. doi:10.1016/j.jaci.2013.04.048
119. Munoz JL, Bliss SA, Greco SJ, Ramkissoon SH, Ligon KL, Rameshwar P (2013) Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity. Mol Ther Nucleic Acids 2:e126. doi:10.1038/mtna.2013.60
120. Ibrahim AG, Cheng K, Marban E (2014) Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports 2(5):606–619. doi:10.1016/j.stemcr.2014.04.006
121. Morel L, Regan M, Higashimori H, Ng SK, Esau C, Vidensky S, Rothstein J, Yang Y (2013) Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1. J Biol Chem 288(10):7105–7116. doi:10.1074/jbc.M112.410944
122. Katakowski M, Buller B, Zheng X, Lu Y, Rogers T, Osobamiro O, Shu W, Jiang F et al (2013) Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett 335(1):201–204. doi:10.1016/j.canlet.2013.02.019
123. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, de Gruijl TD, Wurdinger T et al (2010) Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A 107(14):6328–6333. doi:10.1073/pnas.0914843107
124. Kogure T, Lin WL, Yan IK, Braconi C, Patel T (2011) Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology 54(4):1237–1248. doi:10.1002/hep.24504
125. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654–659. doi:10.1038/ncb1596
126. Yang M, Chen J, Su F, Yu B, Lin L, Liu Y, Huang JD, Song E (2011) Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer 10:117. doi:10.1186/1476-4598-10-117
127. Mittelbrunn M, Gutierrez-Vazquez C, Villarroya-Beltri C, Gonzalez S, Sanchez-Cabo F, Gonzalez MA, Bernad A, Sanchez-Madrid F (2011) Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun 2:282. doi:10.1038/ncomms1285
128. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285 (23):17442–17452. doi:M110.107821
129. Lee YS, Kim SH, Cho JA, Kim CW (2011) Introduction of the CIITA gene into tumor cells produces exosomes with enhanced anti-tumor effects. Exp Mol Med 43(5):281–290. doi:10.3858/emm.2011.43.5.029
130. Akao Y, Iio A, Itoh T, Noguchi S, Itoh Y, Ohtsuki Y, Naoe T (2010) Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. Mol Ther 19(2):395–399. doi:10.1038/mt.2010.254
131. Ozpolat B, Sood AK, Lopez-Berestein G (2014) Liposomal siRNA nanocarriers for cancer therapy. Adv Drug Deliv Rev 66:110–116. doi:10.1016/j.addr.2013.12.008
132. Tabernero J, Shapiro GI, LoRusso PM, Cervantes A, Schwartz GK, Weiss GJ, Paz-Ares L, Cho DC et al (2013) 3rd first-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement. Cancer Discov 3(4):406–417. doi:10.1158/2159-8290.CD-12-0429
133. Morishita M, Takahashi Y, Matsumoto A, Nishikawa M, Takakura Y (2016) Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA. Biomaterials 111:55–65. doi:10.1016/j.biomaterials.2016.09.031
134. Kooijmans SA, Aleza CG, Roffler SR, van Solinge WW, Vader P, Schiffelers RM (2016) Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting. J Extracell Vesicles 5:31053. doi:10.3402/jev.v5.31053
135. Kurowska-Stolarska M, Alivernini S, Ballantine LE, Asquith DL, Millar NL, Gilchrist DS, Reilly J, Ierna M et al (2011) MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A 108(27):11193–11198. doi:10.1073/pnas.1019536108
136. Abdullah M, Takase H, Nunome M, Enomoto H, J-i I, Gong J-S, Michikawa M (2016) Amyloid-β reduces exosome release from astrocytes by enhancing JNK phosphorylation. J Alzheimers Dis 53(4):1433–1441. doi:10.3233/JAD-160292
137. Langui D, Girardot N, El Hachimi KH, Allinquant B, Blanchard V, Pradier L, Duyckaerts C (2004) Subcellular topography of neuronal Aβ peptide in APPxPS1 transgenic mice. Am J Pathol 165(5):1465–1477. doi:10.1016/S0002-9440(10)63405-0
138. Tkach M, Théry C (2016) Communication by extracellular vesicles: where we are and where we need to go. Cell 164(6):1226–1232. doi:10.1016/j.cell.2016.01.043
139. Simons M, Raposo G (2009) Exosomes—vesicular carriers for intercellular communication. Curr Opin Cell Biol 21(4):575–581. doi:10.1016/j.ceb.2009.03.007
140. Potolicchio I, Carven GJ, Xu X, Stipp C, Riese RJ, Stern LJ, Santambrogio L (2005) Proteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism. J Immunol 175(4):2237–2243. doi:10.4049/jimmunol.175.4.2237
141. Gosselin R-D, Meylan P, Decosterd I (2013) Extracellular microvesicles from astrocytes contain functional glutamate transporters: regulation by protein kinase C and cell activation. Front Cell Neurosci 7:251. doi:10.3389/fncel.2013.00251
142. Lachenal G, Pernet-Gallay K, Chivet M, Hemming FJ, Belly A, Bodon G, Blot B, Haase G et al (2011) Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol Cell Neurosci 46(2):409–418. doi:10.1016/j.mcn.2010.11.004
143. Krämer-Albers EM, Bretz N, Tenzer S, Winterstein C, Möbius W, Berger H, Nave KA, Schild H et al (2007) Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: trophic support for axons? Proteomics Clin Appl 1(11):1446–1461. doi:10.1002/prca.200700522
144. Fröhlich D, Kuo WP, Frühbeis C, Sun J-J, Zehendner CM, Luhmann HJ, Pinto S, Toedling J, Trotter J, Krämer-Albers E-M (2014) Multifaceted effects of oligodendroglial exosomes on neurons: impact on neuronal firing rate, signal transduction and gene regulation. Philos Trans R Soc Lond B Biol Sci. ;369(1652). pii: 20130510. doi: 10.1098/rstb.2013.0510
145. Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, Wolozin B, Butovsky O et al (2015) Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci 18(11):1584–1593. doi:10.1038/nn.4132
146. van Balkom BW, De Jong OG, Smits M, Brummelman J, den Ouden K, de Bree PM, van Eijndhoven MA, Pegtel DM, Stoorvogel W, Würdinger T (2013) Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells. Blood 121(19):3997–4006, S1-15. doi: 10.1182/blood-2013-02-478925
147. Gutzeit C, Nagy N, Gentile M, Lyberg K, Gumz J, Vallhov H, Puga I, Klein E et al (2014) Exosomes derived from Burkitt’s lymphoma cell lines induce proliferation, differentiation, and class-switch recombination in B cells. J Immunol 192(12):5852–5862. doi:10.4049/jimmunol.1302068
148. Zhang B, Yin Y, Lai RC, Tan SS, Choo ABH, Lim SK (2013) Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells Dev 23(11):1233–1344. doi:10.1089/scd.2013.0479
149. Verbeek MM, Otte-Höller I, Fransen JA, de Waal RM (2002) Accumulation of the amyloid-β precursor protein in multivesicular body-like organelles. J Histochem Cytochem 50(5):681–690. doi:10.1177/002215540205000509
150. Ehehalt R, Keller P, Haass C, Thiele C, Simons K (2003) Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts. J Cell Biol 160(1):113–123. doi:10.1083/jcb.200207113
151. Saman S, Kim W, Raya M, Visnick Y, Miro S, Saman S, Jackson B, McKee AC et al (2012) Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem 287(6):3842–3849. doi:10.1074/jbc.M111.277061
152. Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, Stefanis L, Vekrellis K (2010) Cell-produced α-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 30(20):6838–6851. doi:10.1523/JNEUROSCI.5699-09.2010
153. Danzer KM, Kranich LR, Ruf WP, Cagsal-Getkin O, Winslow AR, Zhu L, Vanderburg CR, McLean PJ (2012) Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener 7:42. doi:10.1186/1750-1326-7-42
154. van der Pol E, Böing AN, Harrison P, Sturk A, Nieuwland R (2012) Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev 64(3):676–705. doi:10.1124/pr.112.005983
155. Martino G, Hartung H-P (1999) Immunopathogenesis of multiple sclerosis: the role of T cells. Curr Opin Neurol 12(3):309–321
156. Minagar A, Maghzi AH, McGee JC, Alexander JS (2012) Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy. Neurol Res 34(8):738–745. doi:10.1179/1743132812Y.0000000072
157. Manterola L, Guruceaga E, Pérez-Larraya JG, González-Huarriz M, Jauregui P, Tejada S, Diez-Valle R, Segura V et al (2014) A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool. Neuro-Oncology 16(4):520–527. doi:10.1093/neuonc/not218
158. Okoye IS, Coomes SM, Pelly VS, Czieso S, Papayannopoulos V, Tolmachova T, Seabra MC, Wilson MS (2014) MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells. Immunity 1:89–103. doi:10.1016/j.immuni
159. Street JM, Barran PE, Mackay CL, Weidt S, Balmforth C, Walsh TS, Chalmers RT, Webb DJ et al (2012) Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J Transl Med 10:5. doi:10.1186/1479-5876-10-5
160. Cheng L, Sharples RA, Scicluna BJ, Hill AF (2014) Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles 3. doi: 10.3402/jev.v3.23743
161. Cheng L, Sun X, Scicluna BJ, Coleman BM, Hill AF (2014) Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine. Kidney Int 86(2):433–444. doi:10.1038/ki.2013.502
162. Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C, Li Y, Aro P et al (2014) Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease. Acta Neuropathol 128(5):639–650. doi:10.1007/s00401-014-1314-y
163. Tomlinson PR, Zheng Y, Fischer R, Heidasch R, Gardiner C, Evetts S, Hu M, Wade-Martins R et al (2015) Identification of distinct circulating exosomes in Parkinson’s disease. Ann Clin Transl Neurol 2(4):353–361. doi:10.1002/acn3.175
164. Fraser KB, Moehle MS, Daher JP, Webber PJ, Williams JY, Stewart CA, Yacoubian TA, Cowell RM et al (2013) LRRK2 secretion in exosomes is regulated by 14-3-3. Hum Mol Genet 22(24):4988–5000. doi:10.1093/hmg/ddt346
165. Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, Simons K (2006) Alzheimer’s disease β-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A 103(30):11172–11177. doi:10.1073/pnas.0603838103
166. Beal M, Xu H, Greengard P, Gouras G (2002) Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 161:18691879. doi:10.1016/S0002-9440(10)64463-X
167. Vingtdeux V, Hamdane M, Loyens A, Gelé P, Drobeck H, Bégard S, Galas M-C, Delacourte A et al (2007) Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies. J Biol Chem 282(25):18197–18205. doi:10.1074/jbc.M609475200
168. Coleman BM, Hill AF (2015) Extracellular vesicles—their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases. Semin Cell Dev Biol 40:89–96. doi:10.1016/j.semcdb.2015.02.007
169. Feneberg E, Steinacker P, Lehnert S, Schneider A, Walther P, Thal DR, Linsenmeier M, Ludolph AC et al (2014) Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases. Amyotroph Lateral Scler Frontotemporal Degener 15(5–6):351–356. doi:10.3109/21678421.2014.90560
170. Bassil F, Canron M-H, Vital A, Bezard E, Li Y, Greig NH, Gulyani S, Kapogiannis D et al (2017) Insulin resistance and exendin-4 treatment for multiple system atrophy. Brain. doi:10.1093/brain/awx044
171. Ghidoni R, Paterlini A, Albertini V, Glionna M, Monti E, Schiaffonati L, Benussi L, Levy E et al (2011) Cystatin C is released in association with exosomes: a new tool of neuronal communication which is unbalanced in Alzheimer’s disease. Neurobiol Aging 32(8):1435–1442. doi:10.1016/j.neurobiolaging.2009.08.013
172. Katsuda T, Tsuchiya R, Kosaka N, Yoshioka Y, Takagaki K, Oki K, Takeshita F, Sakai Y et al (2013) Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci Rep 3:1197. doi:10.1038/srep01197
173. Wang G, Dinkins M, He Q, Zhu G, Poirier C, Campbell A, Mayer-Proschel M, Bieberich E (2012) Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J Biol Chem 287(25):21384–21395. doi:10.1074/jbc. M112 340513
174. Simpson RJ, Jensen SS, Lim JW (2008) Proteomic profiling of exosomes: current perspectives. Proteomics 8(19):4083–4099. doi:10.1002/pmic.200800109
175. Lionetti V, Bianchi G, Recchia FA, Ventura C (2010) Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure. Heart Fail Rev 15(6):531–542. doi:10.1007/s10741-010-9165-7
176. Vrijsen K, Sluijter J, Schuchardt M, Van Balkom B, Noort W, Chamuleau S, Doevendans P (2010) Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells. J Cell Mol Med 14(5):1064–1070. doi:10.1111/j.1582-4934.2010.01081.x
177. Akers JC, Gonda D, Kim R, Carter BS, Chen CC (2013) Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neuro-Oncol 113(1):1–11. doi:10.1007/s11060-013-1084-8
178. Gambim MH, Do Carmo ADO, Marti L, Veríssimo-Filho S, Lopes LR, Janiszewski M (2007) Platelet-derived exosomes induce endothelial cell apoptosis through peroxynitrite generation: experimental evidence for a novel mechanism of septic vascular dysfunction. Crit Care 11(5):R107. doi:10.1186/cc6133
179. Zhu H, Fan G-C (2011) Extracellular/circulating microRNAs and their potential role in cardiovascular disease. Am J Cardiovasc Dis 1(2):138
180. Gray WD, French KM, Ghosh-Choudhary S, Maxwell JT, Brown ME, Platt MO, Searles CD, Davis ME (2015) Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology. Circ Res 116(2):255–263. doi:10.1161/CIRCRESAHA.116.304360
181. Wang X, Zhu H, Zhang X, Liu Y, Chen J, Medvedovic M, Li H, Weiss MJ et al (2012) Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc Res 94(2):379–390. doi:10.1093/cvr/cvs096
182. Li J, Rohailla S, Gelber N, Rutka J, Sabah N, Gladstone RA, Wei C, Hu P et al (2014) MicroRNA-144 is a circulating effector of remote ischemic preconditioning. Basic Res Cardiol 109(5):423. doi:10.1007/s00395-014-0423-z
183. Singh PP, LeMaire C, Tan JC, Zeng E, Schorey JS (2011) Exosomes released from M. tuberculosis infected cells can suppress IFN-γ mediated activation of naïve macrophages. PLoS One 6(4):e18564. doi:10.1371/journal.pone.0018564
184. Gastpar R, Gehrmann M, Bausero MA, Asea A, Gross C, Schroeder JA, Multhoff G (2005) Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res 65(12):5238–5247. doi:10.1158/0008-5472.CAN-04-3804
185. Wang CY, Yang HB, Hsu HS, Chen LL, Tsai CC, Tsai KS, Yew TL, Kao YH et al (2012) Mesenchymal stem cell-conditioned medium facilitates angiogenesis and fracture healing in diabetic rats. J Tissue Eng Regen Med 6(7):559–569. doi:10.1002/term.461
186. Lehmann SM, Krüger C, Park B, Derkow K, Rosenberger K, Baumgart J, Trimbuch T, Eom G et al (2012) An unconventional role for miRNA: let-7 activates toll-like receptor 7 and causes neurodegeneration. Nat Neurosci 15(6):827–835. doi:10.1038/nn.3113
187. Liu G, Abraham E (2013) MicroRNAs in immune response and macrophage polarization. Arterioscler Thromb Vasc Biol 33(2):170–177. doi:10.1161/ATVBAHA.112.300068
188. Kulshreshtha A, Ahmad T, Agrawal A, Ghosh B (2013) Proinflammatory role of epithelial cell–derived exosomes in allergic airway inflammation. J Allergy Clin Immunol 131 (4):1194–1203, 1203.e1-14. doi: 10.1016/j.jaci.2012.12.1565
189. Pitt JM, André F, Amigorena S, Soria J-C, Eggermont A, Kroemer G, Zitvogel L (2016) Dendritic cell-derived exosomes for cancer therapy. J Clin Invest 126(4):1224–1232. doi:10.1172/JCI81137
190. Schreibelt G, Bol KF, Westdorp H, Wimmers F, Aarntzen EH, Duiveman-de Boer T, van de Rakt MW, Scharenborg NM et al (2016) Effective clinical responses in metastatic melanoma patients after vaccination with primary myeloid dendritic cells. Clin Cancer Res 22(9):2155–2166. doi:10.1158/1078-0432.CCR-15-2205
191. Butz H, Nofech-Mozes R, Ding Q, Khella HW, Szabó PM, Jewett M, Finelli A, Lee J et al (2016) Exosomal microRNAs are diagnostic biomarkers and can mediate cell–cell communication in renal cell carcinoma. European Urology Focus 2(2):210–218. doi:10.1016/j.euf.2015.11.006
192. Turay D, Khan S, Diaz Osterman CJ, Curtis MP, Khaira B, Neidigh JW, Mirshahidi S, Casiano CA et al (2016) Proteomic profiling of serum-derived exosomes from ethnically diverse prostate cancer patients. Cancer Investig 34(1):1–11. doi:10.3109/07357907.2015.1081921
193. Koliha N, Heider U, Ozimkowski T, Wiemann M, Bosio A, Wild S (2016) Melanoma affects the composition of blood cell-derived extracellular vesicles. Front Immunol 7:282. doi:10.3389/fimmu.2016.00282
194. Théry C, Duban L, Segura E, Véron P, Lantz O, Amigorena S (2002) Indirect activation of naïve CD4+ T cells by dendritic cell–derived exosomes. Nat Immunol 3(12):1156–1162. doi:10.1038/ni854
195. André F, Chaput N, Schartz NE, Flament C, Aubert N, Bernard J, Lemonnier F, Raposo G et al (2004) Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J Immun 172(4):2126–2136. doi:10.4049/jimmunol.172.4.2126
196. Tian Y, Li S, Song J, Ji T, Zhu M, Anderson GJ, Wei J, Nie G (2014) A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35(7):2383–2390. doi:10.1016/j.biomaterials.2013.11.083
197. Jang SC, Kim OY, Yoon CM, Choi D-S, Roh T-Y, Park J, Nilsson J, Lötvall J et al (2013) Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano 7(9):7698–7710. doi:10.1021/nn402232g
198. Smyth T, Kullberg M, Malik N, Smith-Jones P, Graner MW, Anchordoquy TJ (2015) Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Release 199:145–155. doi:10.1016/j.jconrel.2014.12.01
199. Lunavat TR, Jang SC, Nilsson L, Park HT, Repiska G, Lässer C, Nilsson JA, Gho YS et al (2016) RNAi delivery by exosome-mimetic nanovesicles—implications for targeting c-Myc in cancer. Biomaterials 102:231–238. doi:10.1016/j.biomaterials.2016.06.024
200. Saari H, Lázaro-Ibáñez E, Viitala T, Vuorimaa-Laukkanen E, Siljander P, Yliperttula M (2015) Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of paclitaxel in autologous prostate cancer cells. J Control Release 220(Pt B):727–737. doi:10.1016/j.jconrel.2015.09.031 737
201. Kim MS, Haney MJ, Zhao Y, Mahajan V, Deygen I, Klyachko NL, Inskoe E, Piroyan A et al (2016) Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine 12(3):655–664. doi:10.1016/j.nano.2015.10.012
202. Pascucci L, Coccè V, Bonomi A, Ami D, Ceccarelli P, Ciusani E, Viganò L, Locatelli A et al (2014) Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J Control Release 192:262–270. doi:10.1016/j.jconrel.2014.07.042
203. Yang T, Martin P, Fogarty B, Brown A, Schurman K, Phipps R, Yin VP, Lockman P et al (2015) Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio. Pharm Res 32(6):2003–2014. doi:10.1007/s11095-014-1593-y
204. Zhuang X, Xiang X, Grizzle W, Sun D, Zhang S, Axtell RC, Ju S, Mu J et al (2011) Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 19(10):1769–1779. doi:10.1038/mt.2011.164
205. Sun D, Zhuang X, Xiang X, Liu Y, Zhang S, Liu C, Barnes S, Grizzle W et al (2010) A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther 18(9):1606–1614. doi:10.1038/mt.2010.105
206. Kalani A, Chaturvedi P, Kamat PK, Maldonado C, Bauer P, Joshua IG, Tyagi SC, Tyagi N (2016) Curcumin-loaded embryonic stem cell exosomes restored neurovascular unit following ischemia-reperfusion injury. Int J Biochem Cell Biol 79:360–369. doi:10.1016/j.biocel.2016.09.002
207. Lotvall J, Valadi H (2007) Cell to cell signalling via exosomes through esRNA. Cell Adhes Migr 1(3):156–158
208. Santangelo L, Giurato G, Cicchini C, Montaldo C, Mancone C, Tarallo R, Battistelli C, Alonzi T et al (2016) The RNA-binding protein SYNCRIP is a component of the hepatocyte exosomal machinery controlling microRNA sorting. Cell Rep 17(3):799–808. doi:10.1016/j.celrep
209. Thakur BK, Zhang H, Becker A, Matei I, Huang Y, Costa-Silva B, Zheng Y, Hoshino A et al (2014) Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res 24(6):766–769. doi:10.1038/cr.2014.44
210. Vlassov AV, Magdaleno S, Setterquist R, Conrad R (2012) Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 1820(7):940–948. doi:10.1016/j.bbagen.2012.03.017
211. Kooijmans S, Vader P, van Dommelen SM, van Solinge WW, Schiffelers RM (2012) Exosome mimetics: a novel class of drug delivery systems. Int J Nanomedicine 7(1525):e41. doi:10.2147/IJN.S29661
212. Lakhal S, Wood MJ (2011) Exosome nanotechnology: an emerging paradigm shift in drug delivery. BioEssays 33(10):737–741. doi:10.1002/bies.201100076
213. Keller S, Ridinger J, Rupp A-K, Janssen JW, Altevogt P (2011) Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med 9:86. doi:10.1186/1479-5876-9-86
214. Théry C, Amigorena S, Raposo G, Clayton A (2006) Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol Chapter 3:Unit 3.22. doi: 10.1002/0471143030.cb0322s30
215. He X, Song W, Liu C, Chen S, Hua J (2014) Rapamycin inhibits acrolein-induced apoptosis by alleviating ROS-driven mitochondrial dysfunction in male germ cells. Cell Prolif 47(2):161–171. doi:10.1111/cpr.12091
216. Takahashi Y, Nishikawa M, Shinotsuka H, Matsui Y, Ohara S, Imai T, Takakura Y (2013) Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol 165(2):77–84. doi:10.1016/j.jbiotec.2013.03.013
217. Bala S, Csak T, Momen-Heravi F, Lippai D, Kodys K, Catalano D, Satishchandran A, Ambros V et al (2015) Biodistribution and function of extracellular miRNA-155 in mice. Sci Rep 5:10721. doi:10.1038/srep10721
218. Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z, Patel T, Piroyan A et al (2015) Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release 207:18–30. doi:10.1016/j.jconrel.2015.03.033
219. Grapp M, Wrede A, Schweizer M, Hüwel S, Galla H-J, Snaidero N, Simons M, Bückers J et al (2013) Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma. Nat Commun 4:2123. doi:10.1038/ncomms3123